T-Vac Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Tetanus toxoid (adsorbed)

Indications/Uses

Prevention of neonatal tetanus by immunizing women of childbearing age, & tetanus in infants, childn & adults especially those exposed to tetanus infection following injury & those engaged in outdoor activities.

Click to view T-Vac detailed prescribing information

Dosage/Direction for Use

IM Deltoid muscle in women & older childn; anterolateral upper thigh in younger childn. Primary immunization 2 dose of 0.5 mL at least 4 wk apart, followed by 3rd dose 6-12 mth later. Booster dose of 0.5 mL is recommended at every feasible interval (5-10 yr for adult. Prevention of neonatal tetanus Previously unimmunized women of childbearing age 5-dose schedule: After basic course w/ 3 dose, 2 additional booster dose at least 1 yr after previous dose or during subsequent pregnancy. Infection w/ injury or other cause >5 yr elapsed after primary or booster dose: 0.5 mL. Inadequate immunization history: 1,500 IU tetanus antiserum + 0.5 mL toxoid in separate syringe administered to different body site. 2nd 0.5 mL dose of toxoid after 2 wk & 3rd dose after further 1 mth is recommended.

Click to view T-Vac detailed prescribing information

Contraindications

Persons w/ severe reaction to previous dose of tetanus toxoid. Defer immunization during the course of any febrile illness or acute infection.

Click to view T-Vac detailed prescribing information

Special Precautions

Ensure that inj does not enter a blood vessel. Observe vaccinees for ≥30 min for possible immediate or early allergic reactions. Use adrenaline inj at the 1st suspicion of anaphylaxis. Hydrocortisone & antihistamine should be available in addition to supportive measures eg, O₂ inhalation. Increased incidence of local & systemic reactions to booster doses when given to previously immunized persons. Caution w/ IM inj in patients on anticoagulant therapy.

Click to view T-Vac detailed prescribing information

Adverse Reactions

Inflammation w/ transient fever, malaise & irritability.

Click to view T-Vac detailed prescribing information

Drug Interactions

Reduced immune response w/ immunosuppressive therapy.

Click to view T-Vac detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view T-Vac detailed prescribing information

Storage

View T-Vac storage conditions for details to ensure optimal shelf-life.

Description

View T-Vac description for details of the chemical structure and excipients (inactive components).

MIMS Class

Vaccines, Antisera & Immunologicals

ATC Classification

J07AM01 - tetanus toxoid ; Belongs to the class of tetanus bacterial vaccines.

Regulatory Classification

Presentation/Packing

Form

T-Vac susp for inj 5 Lf/0.5 mL (10 doses)

Packing/Price

5 mL x 50 × 1's

Form

T-Vac susp for inj 5 Lf/0.5 mL (20 doses)

Packing/Price

10 mL x 25 × 1's

Form

T-Vac susp for inj 5 Lf/0.5 mL (single dose)

Packing/Price

0.5 mL x 50 × 1's

T-Vac

Manufacturer:

Serum Institute of India

Distributor:

Genpharm